Current Drug Therapy
MAO inhibitors: Risks, benefits, and lore
Molly Wimbiscus, MD, Olga Kostenko, MD and Donald Malone, MD
Cleveland Clinic Journal of Medicine December 2010, 77 (12) 859-882; DOI: https://doi.org/10.3949/ccjm.77a.09103
Molly Wimbiscus
Department of Psychiatry and Psychology, Cleveland Clinic
Olga Kostenko
Department of Psychiatry and Psychology, Cleveland Clinic
Donald Malone
Department of Psychiatry and Psychology, Cleveland Clinic
In this issue
Cleveland Clinic Journal of Medicine
Vol. 77, Issue 12
1 Dec 2010
MAO inhibitors: Risks, benefits, and lore
Molly Wimbiscus, Olga Kostenko, Donald Malone
Cleveland Clinic Journal of Medicine Dec 2010, 77 (12) 859-882; DOI: 10.3949/ccjm.77a.09103
Jump to section
Related Articles
- No related articles found.
Cited By...
- Effects of psychedelics on neurogenesis and brain plasticity: A systematic review
- Nuclear GAPDH cascade mediates pathological cardiac hypertrophy
- Targeting monoamine oxidase A for T cell-based cancer immunotherapy
- In Vitro, In Vivo, and Clinical Studies of Tedizolid To Assess the Potential for Peripheral or Central Monoamine Oxidase Interactions